Lucid Pharma Recalls Venlafaxine Hydrochloride Extended-Release Capsules Due to Melted Capsules
Lucid Pharma LLC is recalling specific lots of Venlafaxine Hydrochloride Extended-Release Capsules, 75 mg, because pharmacists reported bottles containing melted capsules.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II. The hazard involves physical defects (melted capsules) without reported illnesses or injuries, fitting the criteria for moderate severity involving low-risk contamination or voluntary precautionary measures.
Plain-English summary
Lucid Pharma LLC is recalling Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, in 30-count and 90-count bottles. The recall involves Lot V17516045-A (expiration 08/18) and Lot V17516047-A (expiration 09/18). The affected products were distributed nationwide in the USA.
The recall was initiated due to pharmacist complaints regarding bottles containing melted capsules. This condition represents a failure to meet tablet/capsule specifications. The source text does not report any illnesses or injuries associated with this defect.
Consumers with these specific products should stop using them and contact their pharmacist or healthcare provider for guidance. The recalled items are prescription-only medications.
The recalled product
- Product
- Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and b) 90-count bottles (NDC 52343-132-90), Rx only, Distributed by: Lucid Pharma LLC, 2 Tower Center Blvd, Suite-1101-B, East Brunswick, NJ 08816 USA.
- Manufacturer
- Lucid Pharma LLC
- Category
- Drug — Prescription Medication
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #: a) V17516045-A
- Exp 08/18
- b) V17516047-A 09/18
Distribution
Distributed nationwide across the United States.
Related recalls
Same hazard · physical defect
See all →- HighThermodilution Catheter May Bend During Use, Causing Monitor Errors
FDA (Devices) · 2023-04-19
- ModerateBard Clean-Cath Intermittent Catheter Recalled for Packaging and Tip Defects
FDA (Devices) · 2021-04-28
- HighFerring Recalls ZOMA-Jet 5 Demonstration Kits Due to Defective Delivery System
FDA (Drugs) · 2021-04-07
- HighROi CPS Recalls Custom Procedure Packs with Flaking Gauze Sponges
FDA (Devices) · 2021-01-06
- HighGE Healthcare Recalls Flow Sensor Service Parts with Damaged Tubes
FDA (Devices) · 2020-11-11